RIMINDER

Welcome to the Brand page for “RIMINDER”, which is offered here for Adjuvants for medical purposes; antiallergic medicines; anti-cancer preparations; medicinal herbal extracts for medical purposes; pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; dietary and nutritional supplements for medical use; dietary supplements for treating fatigue or liver support; animal feed additive for use as a nutritional supplement for medical purposes; dietary supplements for human consumption or for animals; nutritional additives for medical purposes for use in foods for human consumption or for animals; animal feed supplements; dietary pet supplements in the form of pet treats; fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments. pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; cardiovascular pharmaceuticals; cardiovascular treatment preparations; pharmaceuticals preparations for the treatment of kidney diseases;.

Its status is currently believed to be active. Its class is unavailable. “RIMINDER” is believed to be currently owned by “GOLDEN BIOTECHNOLOGY CORPORATION”.